Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      
Antibody Engineering and Therapeutics Europe

Antibody Engineering and Therapeutics Europe

Categories

Date of beginning

Tuesday, 11 June 2019

Duration

3 days

Deadline for abstracts

Friday, 17 May 2019

City

Amsterdam

Country

Netherlands

Contact

Frances Pratt

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Memo

Antibody Engineering and Therapeutics Europe, 11 - 13 June 2019 in Amsterdam, is the #1 antibody meeting in Europe bringing together world-renowned scientists and academic researchers to deliver the latest science, technologies and partners needed to help you accelerate next generation antibodies towards commercial success. Sessions and Workshops Around 8 Key Themes:Turning Antibody Leads into DrugsRecent Advances in Immuno-Oncology ApproachesBioinformatics and Repertoires in Antibody Discovery and DevelopmentAntibody Therapeutics for Autoimmune and Neurodegenerative DiseasesClinical Developments in Antibody TherapeuticsNew Antibody Formats and Effector FunctionsBispecific Antibodies: New Strategies and Case StudiesAntibody Drug Conjugates (ADCs): New Strategies and Case Studies Don't Wait! This event sold out last year and had to be moved to a new venue this year! Visit: AntibodyEngEu On Tuesday June 11, 2019 at 8:00 am (ends Thursday June 13, 2019 at 5:00 pm) Prices: Industry - Conference Only: GBP 1399.0Academic - Conference Only: GBP 499.0 URL: Tickets: https://go.evvnt.com/341327-2?pid=5569 Speakers: Jane Osbourn, Ph.D. Vice President R&D and Site Leader at Medimmune, Hans Clevers, M.D., Ph.D. Group Leader and Professor of Molecular Genetics at Hubrecht Institute for Developmental Biology and Stem Cell Research and University Medical Center Utrecht and Utrecht University, Ton Logtenberg, PhD, President and CEO, Merus N.V., Allan Bradley, PhD, Chief Scientific Officer, Kymab Limited Venue details: Postillion Hotel Amsterdam, BW Signature Collection, 9-11 Paul van Vlissingenstraat, Amsterdam, 1096 BK, Netherlands